HEADER TRANSFERASE 23-APR-03 1P4F TITLE DEATH ASSOCIATED PROTEIN KINASE CATALYTIC DOMAIN WITH BOUND INHIBITOR TITLE 2 FRAGMENT COMPND MOL_ID: 1; COMPND 2 MOLECULE: DEATH-ASSOCIATED PROTEIN KINASE 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, PROTEIN KINASE DOMAIN; COMPND 5 SYNONYM: DAP KINASE 1; COMPND 6 EC: 2.7.1.-; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: DAPK1 OR DAPK; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TRANSFERASE, KINASE EXPDTA X-RAY DIFFRACTION AUTHOR A.V.VELENTZA,M.S.WAINWRIGHT,M.ZASADZKI,S.MIRZOEVA,J.HAIECH,P.J.FOCIA, AUTHOR 2 M.EGLI,D.M.WATTERSON REVDAT 5 15-SEP-21 1P4F 1 COMPND REMARK HET HETNAM REVDAT 5 2 1 FORMUL ATOM REVDAT 4 24-JUL-19 1P4F 1 REMARK REVDAT 3 11-OCT-17 1P4F 1 REMARK REVDAT 2 24-FEB-09 1P4F 1 VERSN REVDAT 1 28-SEP-04 1P4F 0 JRNL AUTH A.V.VELENTZA,M.S.WAINWRIGHT,M.ZASADZKI,S.MIRZOEVA, JRNL AUTH 2 A.M.SCHUMACHER,J.HAIECH,P.J.FOCIA,M.EGLI,D.M.WATTERSON JRNL TITL AN AMINOPYRIDAZINE-BASED INHIBITOR OF A PRO-APOPTOTIC JRNL TITL 2 PROTEIN KINASE ATTENUATES HYPOXIA-ISCHEMIA INDUCED ACUTE JRNL TITL 3 BRAIN INJURY. JRNL REF BIOORG.MED.CHEM.LETT. V. 13 3465 2003 JRNL REFN ISSN 0960-894X JRNL PMID 14505650 JRNL DOI 10.1016/S0960-894X(03)00733-9 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0003 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 94.9 REMARK 3 NUMBER OF REFLECTIONS : 19405 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.186 REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.233 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.900 REMARK 3 FREE R VALUE TEST SET COUNT : 778 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.95 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1296 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 87.89 REMARK 3 BIN R VALUE (WORKING SET) : 0.1960 REMARK 3 BIN FREE R VALUE SET COUNT : 54 REMARK 3 BIN FREE R VALUE : 0.2680 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2188 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 15 REMARK 3 SOLVENT ATOMS : 182 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.14 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.37000 REMARK 3 B22 (A**2) : 0.69000 REMARK 3 B33 (A**2) : -1.06000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.177 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.160 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.098 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.201 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.947 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.924 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2238 ; 0.011 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3026 ; 1.216 ; 1.959 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 270 ; 5.137 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 106 ;37.375 ;24.434 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 392 ;13.251 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 12 ;20.125 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 336 ; 0.085 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1694 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 968 ; 0.202 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1549 ; 0.308 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 221 ; 0.125 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 68 ; 0.210 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 28 ; 0.172 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1396 ; 0.993 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2187 ; 1.310 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 965 ; 2.064 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 839 ; 3.195 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 1P4F COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-MAY-03. REMARK 100 THE DEPOSITION ID IS D_1000018993. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-NOV-02 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 5ID-B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : SI III REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MAR REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20869 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.9 REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : 0.04900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 25.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.3 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.21300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.520 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1JKL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 34.37 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.89 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: AMMONIUM SULFATE, TRIS, MGCL2, PH 7.5, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 297K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 23.61900 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 44.46350 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 31.26350 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 44.46350 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 23.61900 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 31.26350 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A 105 REMARK 465 ALA A 106 REMARK 465 GLU A 107 REMARK 465 LYS A 108 REMARK 465 GLU A 109 REMARK 465 SER A 110 REMARK 465 LEU A 111 REMARK 465 PRO A 153 REMARK 465 LYS A 154 REMARK 465 LYS A 278 REMARK 465 ASP A 279 REMARK 465 THR A 280 REMARK 465 GLN A 281 REMARK 465 GLN A 282 REMARK 465 ALA A 283 REMARK 465 LEU A 284 REMARK 465 SER A 285 REMARK 465 SER A 286 REMARK 465 ALA A 287 REMARK 465 TRP A 288 REMARK 465 SER A 289 REMARK 465 HIS A 290 REMARK 465 PRO A 291 REMARK 465 GLU A 294 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 GLU A 7 CD OE1 OE2 REMARK 480 LYS A 45 CD CE NZ REMARK 480 ARG A 48 CG CD NE CZ NH1 NH2 REMARK 480 GLN A 72 CG CD OE1 NE2 REMARK 480 GLU A 114 CD OE1 OE2 REMARK 480 GLU A 115 CG CD OE1 OE2 REMARK 480 ASP A 169 CG OD1 OD2 REMARK 480 LYS A 222 CE NZ REMARK 480 ASN A 243 CG OD1 ND2 REMARK 480 GLN A 292 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 139 36.34 -141.66 REMARK 500 ASP A 161 80.94 56.28 REMARK 500 LYS A 175 28.96 -160.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 86Q A 295 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1IG1 RELATED DB: PDB REMARK 900 RELATED ID: 1JKK RELATED DB: PDB REMARK 900 RELATED ID: 1JKL RELATED DB: PDB REMARK 900 RELATED ID: 1JKS RELATED DB: PDB REMARK 900 RELATED ID: 1JKT RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THESE RESIDUES CORRESPOND TO A C-TERMINAL STREPTAVIDIN TAG. DBREF 1P4F A 2 285 UNP P53355 DAPK1_HUMAN 2 285 SEQADV 1P4F SER A 286 UNP P53355 SEE REMARK 999 SEQADV 1P4F ALA A 287 UNP P53355 SEE REMARK 999 SEQADV 1P4F TRP A 288 UNP P53355 SEE REMARK 999 SEQADV 1P4F SER A 289 UNP P53355 SEE REMARK 999 SEQADV 1P4F HIS A 290 UNP P53355 SEE REMARK 999 SEQADV 1P4F PRO A 291 UNP P53355 SEE REMARK 999 SEQADV 1P4F GLN A 292 UNP P53355 SEE REMARK 999 SEQADV 1P4F PHE A 293 UNP P53355 SEE REMARK 999 SEQADV 1P4F GLU A 294 UNP P53355 SEE REMARK 999 SEQRES 1 A 293 THR VAL PHE ARG GLN GLU ASN VAL ASP ASP TYR TYR ASP SEQRES 2 A 293 THR GLY GLU GLU LEU GLY SER GLY GLN PHE ALA VAL VAL SEQRES 3 A 293 LYS LYS CYS ARG GLU LYS SER THR GLY LEU GLN TYR ALA SEQRES 4 A 293 ALA LYS PHE ILE LYS LYS ARG ARG THR LYS SER SER ARG SEQRES 5 A 293 ARG GLY VAL SER ARG GLU ASP ILE GLU ARG GLU VAL SER SEQRES 6 A 293 ILE LEU LYS GLU ILE GLN HIS PRO ASN VAL ILE THR LEU SEQRES 7 A 293 HIS GLU VAL TYR GLU ASN LYS THR ASP VAL ILE LEU ILE SEQRES 8 A 293 LEU GLU LEU VAL ALA GLY GLY GLU LEU PHE ASP PHE LEU SEQRES 9 A 293 ALA GLU LYS GLU SER LEU THR GLU GLU GLU ALA THR GLU SEQRES 10 A 293 PHE LEU LYS GLN ILE LEU ASN GLY VAL TYR TYR LEU HIS SEQRES 11 A 293 SER LEU GLN ILE ALA HIS PHE ASP LEU LYS PRO GLU ASN SEQRES 12 A 293 ILE MET LEU LEU ASP ARG ASN VAL PRO LYS PRO ARG ILE SEQRES 13 A 293 LYS ILE ILE ASP PHE GLY LEU ALA HIS LYS ILE ASP PHE SEQRES 14 A 293 GLY ASN GLU PHE LYS ASN ILE PHE GLY THR PRO GLU PHE SEQRES 15 A 293 VAL ALA PRO GLU ILE VAL ASN TYR GLU PRO LEU GLY LEU SEQRES 16 A 293 GLU ALA ASP MET TRP SER ILE GLY VAL ILE THR TYR ILE SEQRES 17 A 293 LEU LEU SER GLY ALA SER PRO PHE LEU GLY ASP THR LYS SEQRES 18 A 293 GLN GLU THR LEU ALA ASN VAL SER ALA VAL ASN TYR GLU SEQRES 19 A 293 PHE GLU ASP GLU TYR PHE SER ASN THR SER ALA LEU ALA SEQRES 20 A 293 LYS ASP PHE ILE ARG ARG LEU LEU VAL LYS ASP PRO LYS SEQRES 21 A 293 LYS ARG MET THR ILE GLN ASP SER LEU GLN HIS PRO TRP SEQRES 22 A 293 ILE LYS PRO LYS ASP THR GLN GLN ALA LEU SER SER ALA SEQRES 23 A 293 TRP SER HIS PRO GLN PHE GLU HET 86Q A 295 15 HETNAM 86Q 5,6-DIHYDRO-BENZO[H]CINNOLIN-3-YLAMINE FORMUL 2 86Q C12 H11 N3 FORMUL 3 HOH *182(H2 O) HELIX 1 1 ASN A 8 ASP A 11 5 4 HELIX 2 2 SER A 57 ILE A 71 1 15 HELIX 3 3 THR A 112 LEU A 133 1 22 HELIX 4 4 LYS A 141 GLU A 143 5 3 HELIX 5 5 THR A 180 VAL A 184 5 5 HELIX 6 6 ALA A 185 ASN A 190 1 6 HELIX 7 7 LEU A 196 GLY A 213 1 18 HELIX 8 8 THR A 221 VAL A 232 1 12 HELIX 9 9 GLU A 237 SER A 242 1 6 HELIX 10 10 SER A 245 ARG A 254 1 10 HELIX 11 11 ASP A 259 ARG A 263 5 5 HELIX 12 12 THR A 265 HIS A 272 1 8 SHEET 1 A 5 TYR A 13 SER A 21 0 SHEET 2 A 5 ALA A 25 GLU A 32 -1 O LYS A 29 N GLU A 17 SHEET 3 A 5 GLN A 38 LYS A 45 -1 O PHE A 43 N VAL A 26 SHEET 4 A 5 ASP A 88 GLU A 94 -1 O VAL A 89 N ILE A 44 SHEET 5 A 5 LEU A 79 GLU A 84 -1 N GLU A 81 O ILE A 92 SHEET 1 B 2 ILE A 135 ALA A 136 0 SHEET 2 B 2 HIS A 166 LYS A 167 -1 O HIS A 166 N ALA A 136 SHEET 1 C 2 ILE A 145 LEU A 147 0 SHEET 2 C 2 ILE A 157 ILE A 159 -1 O LYS A 158 N MET A 146 SITE 1 AC1 10 SER A 21 GLY A 22 VAL A 27 ALA A 40 SITE 2 AC1 10 LYS A 42 GLU A 94 VAL A 96 ILE A 160 SITE 3 AC1 10 ASP A 161 HOH A 311 CRYST1 47.238 62.527 88.927 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021169 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015993 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011245 0.00000